FAETH THERAPEUTICS ANNOUNCES FDA GRANT OF FAST TRACK DESIGNATION FOR PIKTOR PLUS PACLITAXEL IN BIOMARKER-SELECTED ADVANCED ENDOMETRIAL CANCER

Reuters · 1d ago

Please log in to view news